Home
About
Overview
Sharing Data
ORCID
Help
History (31)
Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.
Somatic and germline mosaic mutations in the doublecortin gene are associated with variable phenotypes.
Characterization of mutations in the gene doublecortin in patients with double cortex syndrome.
Developmental aspects of lissencephaly and the lissencephaly syndromes.
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
See All 31 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol. 2000 Apr; 18(8):1652-61.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Combined Modality Therapy
Disease Progression
Female
Fluorouracil
Head and Neck Neoplasms
Humans
Hydroxyurea
Interferon-alpha
Male
Quality of Life
Radiotherapy
Radiotherapy Dosage
Recombinant Proteins
Survival Rate
Tretinoin
authors with profiles
Kerstin M. Stenson
Ralph Weichselbaum
Mary Dolan
Daniel Haraf
Everett Vokes